Timothy Schmid - 09 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, WW Chair, MedTech
Signature
/s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid
Issuer symbol
JNJ
Transactions as of
09 Feb 2026
Net transactions value
$0
Form type
4
Filing time
11 Feb 2026, 20:41:29 UTC
Previous filing
10 Feb 2026
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Schmid Timothy EVP, WW Chair, MedTech ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for Timothy Schmid 11 Feb 2026 0001998491

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Performance Share Units Award $0 +4,378 $0.000000 4,378 09 Feb 2026 Common Stock 4,378 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting.
F2 The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026.